These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3455835)

  • 1. The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia.
    Fontana JA; Rogers JS; Durham JP
    Cancer; 1986 Jan; 57(2):209-17. PubMed ID: 3455835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia.
    Nilsson B
    Br J Haematol; 1984 Jul; 57(3):365-71. PubMed ID: 6589010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 13-cis retinoic acid and Ara-C on differentiation and proliferation of non-promyelocytic acute myelogenous leukemia.
    Hofmann V; Berens ME; Moreillon MC; Cogoli M; Früh U; Merchant RE; Kistler G
    Leuk Res; 1985; 9(11):1367-71. PubMed ID: 3866117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
    Huang ME; Ye YC; Chen SR; Chai JR; Lu JX; Zhoa L; Gu LJ; Wang ZY
    Blood; 1988 Aug; 72(2):567-72. PubMed ID: 3165295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of refractory undifferentiated acute myelogenous leukemia with all-trans-retinoic acid.
    Griggs JJ; Henley SE; Rowe JM
    Am J Hematol; 1994 Feb; 45(2):177-80. PubMed ID: 8141124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
    Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
    Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid.
    Breitman TR; Collins SJ; Keene BR
    Blood; 1981 Jun; 57(6):1000-4. PubMed ID: 6939451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.
    Frankel SR; Eardley A; Heller G; Berman E; Miller WH; Dmitrovsky E; Warrell RP
    Ann Intern Med; 1994 Feb; 120(4):278-86. PubMed ID: 8291820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid-induced differentiation of the human promyelocytic leukemia cell line, HL-60, and fresh human leukemia cells in primary culture: a model for differentiation inducing therapy of leukemia.
    Imaizumi M; Breitman TR
    Eur J Haematol; 1987 Apr; 38(4):289-302. PubMed ID: 3038598
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of neutrophilic differentiation of human promyelocytic leukemic cells by branched-chain carboxylic acid anticonvulsant drugs.
    Fischkoff SA; Walter E
    J Biol Response Mod; 1984; 3(2):132-7. PubMed ID: 6427413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating agents in the treatment of leukemia.
    Degos L
    Leuk Res; 1990; 14(8):717-9. PubMed ID: 2201823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia.
    Daenen S; Vellenga E; van Dobbenburgh OA; Halie MR
    Blood; 1986 Feb; 67(2):559-61. PubMed ID: 3455829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New facts and speculations on human myeloid leukemias.
    Breitman TR; Gallo RC
    Blood Cells; 1981; 7(1):79-89. PubMed ID: 6964818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in effects of interferon-alpha and interferon-gamma on the induction of differentiation of retinoic acid-treated acute myeloid leukemia cells in primary culture.
    Nakamaki T; Sakashita A; Hino K; Suzuki K; Tomoyasu S; Tsuruoka N; Honma Y; Hozumi M
    Leuk Res; 1990; 14(9):785-94. PubMed ID: 2172660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation in acute myeloid leukemia and myelodysplastic disorders. Is differentiation-induction therapy possible?
    Januszewicz EH; Firkin FC
    Aust N Z J Med; 1988 Aug; 18(5):705-11. PubMed ID: 3072952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy between in-vitro and in-vivo inductions of differentiation by retinoids of human acute promyelocytic leukemia cells in relapse.
    Sampi K; Honma Y; Hozumi M; Sakurai M
    Leuk Res; 1985; 9(12):1475-8. PubMed ID: 3866121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid.
    Drach J; Lopez-Berestein G; McQueen T; Andreeff M; Mehta K
    Cancer Res; 1993 May; 53(9):2100-4. PubMed ID: 8481912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-B-D arabinofuranosyl cytosine and all-trans retinoic acid in combination accelerates and increases monocyte differentiation of myeloid leukemic cells.
    Chomienne C; Balitrand N; Degos L; Abita JP
    Leuk Res; 1986; 10(6):631-6. PubMed ID: 3458976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations.
    Flynn PJ; Miller WJ; Weisdorf DJ; Arthur DC; Brunning R; Branda RF
    Blood; 1983 Dec; 62(6):1211-7. PubMed ID: 6580050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.